Top Markets
#1 QuantixAI QuantixAI +102.83%
#2 MetaDAO MetaDAO +25.19%
#3 龙虾 (Lobster) 龙虾 (Lobster) +23.59%
#4 Pons Pons +23.51%
#5 Rain Rain +21.62%
#6 Bedrock Bedrock +21.46%
#7 Ontology Gas Ontology Gas +20.86%
#8 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +20.37%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +19.56%
#10 SPX6900 SPX6900 +18.54%
Coin of the day
QuantixAI QuantixAI
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Grifols, S.A. Grifols, S.A.

Grifols, S.A.

GRF
Classifica tra le azioni #2542
Grifols, S.A., a Spanish company established in 1940 and headquartered in... Grifols, S.A., a Spanish company established in 1940 and headquartered in Barcelona, specializes in the comprehensive process of acquiring, manufacturing, preparing, and distributing therapeutic products, with a primary focus on those derived from plasma. The company operates through several key divisions: Bioscience, Hospital, Diagnostic, and Bio Supplies, among others. The Bioscience division is dedicated to the research, development, production, and commercialization of plasma-derived medicines and other cutting-edge solutions. These are designed to treat individuals suffering from chronic, rare, widespread, and life-threatening medical conditions, with its product portfolio including immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division supplies a range of non-biological pharmaceutical products, clinical nutrition items, intravenous (IV) therapy solutions, and various medical devices and supplies. Grifols' Diagnostic division develops and markets advanced diagnostic tools that support healthcare professionals across the entire patient care continuum, from prevention and screening to accurate diagnosis, prognosis, and ongoing disease and treatment monitoring. Finally, the Bio Supplies division provides essential biological materials for life-science research, clinical trials, and the manufacturing of both pharmaceutical and diagnostic goods. Collectively, Grifols' offerings enable healthcare providers to effectively diagnose and treat a broad spectrum of medical conditions, such as hemophilia, various immune deficiencies, and infectious diseases. Its diverse client base includes public and private sector organizations, wholesalers, distributors, group purchasing organizations (GPOs), blood banks, hospitals, care institutions, and national health systems. Grifols also maintains a technology collaboration agreement with Mondragon.
Prezzo delle azioni
$11.91
Capitalizzazione di mercato
$8.11B
Variazione (1 giorno)
1.67%
Variazione (1 anno)
-16.23%
Paese
ES
Scambia Grifols, S.A. (GRF)

Categoria

Healthcare
Numero di azioni in circolazione per Grifols, S.A. (GRF)
Numero di azioni in circolazione al August 2026: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Grifols, S.A., il numero attuale di azioni in circolazione è 0. Alla fine del August 2026, la società aveva 0 azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di Grifols, S.A. (GRF) dal 2026 al 2026
Azioni in circolazione alla fine di ogni anno
Anno Azioni in circolazione Cambia
Non abbastanza dati per le date fornite.
Azioni in circolazione per aziende simili o concorrenti
Azienda Azioni in circolazione Differenza Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.44B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 0.00 -
US